Revance Therapeutics, Inc.

Quick facts

Marketed products

• DAXXIFY · Other
• DAXXIFY · Other

Phase 3 pipeline

• DaxibotulinumtoxinA for injection · Aesthetics, Neurology
  DaxibotulinumtoxinA is a botulinum toxin that blocks acetylcholine release at the neuromuscular junction, causing temporary muscle paralysis.

Phase 2 pipeline

• DAXI 120 U
• DAXI 80 U
• DAXI for injection 250 U · Aesthetics / Neurology
  DAXI is a botulinum toxin type A formulation that blocks acetylcholine release at the neuromuscular junction to reduce muscle contractions.
• DAXI for injection 375 U
• DAXI for injection 500 U

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Revance Therapeutics, Inc. portfolio CI brief
• Revance Therapeutics, Inc. pipeline updates RSS